Article | July 27, 2023

Outsourcing: Biomanufacturers May Need Consultants More Than Ever

Source: Cytiva
GettyImages-1455959081 handshake

Are consultants more important than ever when it comes to outsourcing drug development and manufacturing? In a webinar presented by Outsourced Pharma Live and sponsored by Cytiva, Louis Garguilo, Chief Editor at Outsourced Pharma, welcomed a panel of experts to explore the role of consultants today and the industry trends that influence an organization’s relationship with them. The panelists covered all the modalities, including small and large molecules and advanced therapeutic medicinal products (ATMPs), as they discussed best practices for selecting and working with consultants and CDMOs as part of an organization’s outsourcing strategy.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development